BiotechTube
Home/OverT Bio/Dr. Mat Legut
DM

Dr. Mat Legut

Chief Executive Officer

OverT Bio

Therapeutic Areas

OncologySolid Tumors

OverT Bio Pipeline

DrugIndicationPhase
OVT-101Ovarian Cancer & Other Solid TumorsPre-clinical
OVT-201Solid TumorsDiscovery

Leadership Team at OverT Bio

CB
Christine Baker
Corporate & Business Development Advisor
SC
Sara Choi
Board Member
VC
Vicki Coutinho
Board Member
View full OverT Bio profile